| Ku Health Partners, Inc | |
|
3901 Rainbow Blvd # Ms 3707 Kansas City KS 66160-0001 | |
| (913) 588-5277 | |
| (913) 588-1693 |
| Full Name | Ku Health Partners, Inc |
|---|---|
| Speciality | Audiologist |
| Location | 3901 Rainbow Blvd # Ms 3707, Kansas City, Kansas |
| Authorized Official Name and Position | Erin Manuel (TREASURER) |
| Authorized Official Contact | 9133752999 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ku Health Partners, Inc 3901 Rainbow Blvd # Ms 3707 Kansas City KS 66160-8500 Ph: (913) 588-5277 | Ku Health Partners, Inc 3901 Rainbow Blvd # Ms 3707 Kansas City KS 66160-0001 Ph: (913) 588-5277 |
| NPI Number | 1043323736 |
|---|---|
| Provider Enumeration Date | 08/16/2006 |
| Last Update Date | 10/01/2020 |
| Medicare PECOS PAC ID | 4183670920 |
|---|---|
| Medicare Enrollment ID | O20050324000956 |
News Archive
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043323736 | NPI | - | NPPES |
| 100452940A | Medicaid | KS | |
| 31306018 | Other | KS | BCBS-KS |
| M200000 | Other | KS | MEDICARE ID |
| Provider Name | Hannah E Maxfield |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1689629958 PECOS PAC ID: 7517960974 Enrollment ID: I20060824000560 |
News Archive
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
› Verified 9 days ago
| Provider Name | Joann Peterson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013070390 PECOS PAC ID: 1850391210 Enrollment ID: I20070109000116 |
News Archive
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
› Verified 9 days ago
| Provider Name | Debora A Daniels |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1821102880 PECOS PAC ID: 8426195884 Enrollment ID: I20091019000021 |
News Archive
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
› Verified 9 days ago
| Provider Name | Lindsey B Heidrick |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1679612469 PECOS PAC ID: 0345433991 Enrollment ID: I20101015000307 |
News Archive
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
› Verified 9 days ago
| Provider Name | Yvonne S Ornelas Rios |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306826227 PECOS PAC ID: 8224167630 Enrollment ID: I20121025000349 |
News Archive
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
› Verified 9 days ago
| Provider Name | Cole M Campbell |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1295098960 PECOS PAC ID: 1658522206 Enrollment ID: I20151104002377 |
News Archive
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
› Verified 9 days ago
| Provider Name | Christine Louise Lightfoot |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457507352 PECOS PAC ID: 9830121235 Enrollment ID: I20160519001422 |
News Archive
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
› Verified 9 days ago
| Provider Name | Carol Buller |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811940059 PECOS PAC ID: 6901831221 Enrollment ID: I20160824000917 |
News Archive
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
› Verified 9 days ago
| Provider Name | Janice Richbourg |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1962673806 PECOS PAC ID: 1052474988 Enrollment ID: I20220617002220 |
News Archive
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
› Verified 9 days ago
News Archive
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
› Verified 9 days ago
Swope Health Services Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4835 State Ave, Kansas City, KS 66102 Phone: 913-321-2200 | |
Creative Health Care Management Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2300 N 113th Ter, Kansas City, KS 66109 Phone: 317-204-3736 Fax: 317-449-5783 | |
Professional Services Of Ku Hospital Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4810 State Ave, Professional Services Of Ku Hospital, Kansas City, KS 66102 Phone: 913-321-4567 Fax: 913-321-6789 | |
Access Health & Injury Solutions, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9535 State Ave, Kansas City, KS 66111 Phone: 913-299-0911 Fax: 913-788-9679 | |
Centerwell Senior Primary Care- State Avenue Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7527 State Ave, Kansas City, KS 66112 Phone: 913-335-6986 Fax: 855-446-7151 | |
Alanna Lee Md An Operating Division Of Providence Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2040 Hutton Rd, Suite 102, Kansas City, KS 66109 Phone: 913-299-3700 Fax: 913-299-3050 |